Physician

Daniel Rahul Agarwal, M.D.

According to 2025 Medicare claims, Daniel Agarwal, M.D. (NPI: 1811230766) practices ophthalmology in the San Luis Obispo-Paso Robles, CA market, with the plurality of this provider's patient population coming from San Luis Obispo, CA. This provider's primary affiliated billing organization is SAN LUIS OBISPO EYE ASSOCIATES, A MEDICAL GROUP INC. (NPI: 1548311061; TIN: 770410120) and primary practice location at 93401-7077.

Agarwal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,045 traditional Medicare patients, billed 52,287 HCPCS/CPT codes, and received $2,349,571 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 594 prescription claims across 165 beneficiaries totaling $30,744 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 23 records totaling $3,270. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,539 to $2,349,571. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,621 to $30,744. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	18	27	$1,539
2018	42	62	$4,992
2019	92	128	$10,918
2020	366	1,114	$98,425
2021	560	2,702	$294,205
2022	716	11,159	$1,867,267
2023	915	39,576	$2,409,396
2024	1,045	52,287	$2,349,571

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	20	$1,621
2016	12	39	$5,802
2017	N/R	15	$5,382
2018	24	57	$4,692
2019	35	99	$12,962
2020	78	193	$19,324
2021	122	496	$50,838
2022	121	336	$28,354
2023	154	570	$40,538
2024	165	594	$30,744

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	182	189	$136
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	960	1,923	$94
67028	Injection of drug into eye	229	1,342	$89
92134	Imaging of retina	1,024	2,760	$31
J2777	Injection, faricimab-svoa, 0.1 mg	131	43,500	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	124	4,164	$4,760
Difluprednate	Difluprednate	22	698	$3,211
Bromfenac Sodium	Bromfenac Sodium	13	300	$2,347
Ketorolac Tromethamine	Ketorolac Tromethamine	80	2,883	$1,640
Moxifloxacin	Moxifloxacin Hcl	50	856	$1,050

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$3,270	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Rahul Agarwal, M.D.?

Tedicare shows public-source Medicare data for Daniel Rahul Agarwal, M.D. (NPI 1811230766), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Rahul Agarwal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Rahul Agarwal, M.D.?

Daniel Rahul Agarwal, M.D. is linked to SAN LUIS OBISPO EYE ASSOCIATES, A MEDICAL GROUP INC. (billing NPI 1548311061) in the available physician profile data.

Does Daniel Rahul Agarwal, M.D. have Open Payments data?

Daniel Rahul Agarwal, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.